Clinically targeted screening for congenital CMV - potential for integration into the National Hearing Screening Programme
- 8 August 2013
- journal article
- research article
- Published by Wiley in Acta Paediatrica
- Vol. 102 (10) , 928-933
Abstract
Screening for a condition should only be undertaken if certain strict criteria are met. Congenital CMV (cCMV) is a leading cause of sensorineuronal hearing loss (SNHL) and meets many of these criteria, but is not currently screened for in the UK. Ganciclovir reduces CMV‐induced progressive SNHL if treatment is begun in the first month of life. The Newborn Hearing Screening Programme (NHSP) has been shown to identify SNHL at the earliest possible age. The potential of integrating screening for cCMV into the NHSP is discussed to consolidate the link between screening, early diagnosis and management. Conclusion The early diagnosis and treatment of cCMV may prevent a small proportion of late SNHL. In the absence of any screening programme, we provide evidence that clinically targeted screening through the NHSP is a potential option in the UK, enhancing the diagnostic pathway and enabling appropriate early treatment to reduce long‐term morbidity.Keywords
This publication has 24 references indexed in Scilit:
- Saliva Polymerase-Chain-Reaction Assay for Cytomegalovirus Screening in NewbornsNew England Journal of Medicine, 2011
- Dried Blood Spot Real-time Polymerase Chain Reaction Assays to Screen Newborns for Congenital Cytomegalovirus InfectionJAMA, 2010
- Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous systemJournal of Clinical Virology, 2009
- Pharmacokinetic and Pharmacodynamic Assessment of Oral Valganciclovir in the Treatment of Symptomatic Congenital Cytomegalovirus DiseaseThe Journal of Infectious Diseases, 2008
- Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: A quantitative assessmentJournal of Clinical Virology, 2008
- External quality assessment of cytomegalovirus DNA detection on dried blood spotsBMC Microbiology, 2008
- Newborn Hearing Screening — A Silent RevolutionNew England Journal of Medicine, 2006
- Language Ability after Early Detection of Permanent Childhood Hearing ImpairmentNew England Journal of Medicine, 2006
- Impact of Family Health Insurance and Other Environmental Factors on Universal Hearing Screen Program EffectivenessJournal of Perinatology, 2002
- Newborn hearing screening: Will children with hearing loss caused by congenital cytomegalovirus infection be missed?The Journal of Pediatrics, 1999